Copyright: ©Author(s) 2026.
World J Cardiol. May 26, 2026; 18(5): 119429
Published online May 26, 2026. doi: 10.4330/wjc.v18.i5.119429
Published online May 26, 2026. doi: 10.4330/wjc.v18.i5.119429
Table 2 Admission biomarkers according to 3-month survival status, median, (interquartile range)
| Variable | Survivors (n = 146) | Non-survivors (n = 25) | P value |
| Age, years | 66 (58-73) | 75 (69-82) | < 0.001 |
| Admission glucose, (mmol/L) | 7.20 (6.30-8.50) | 9.10 (8.10-11.40) | 0.012 |
| HbA1c (%) | 6.1 (5.7-7.0) | 6.2 (5.8-7.2) | 0.528 |
| Stress hyperglycemia ratio | 0.90 (0.78-1.05) | 1.18 (1.02-1.35) | 0.018 |
| Admission glucose-to-chronic glycemia ratio | 0.76 (0.68-0.88) | 0.99 (0.87-1.12) | 0.016 |
| C-reactive protein (mg/L) | 9.0 (4.0-18.0) | 30.4 (18.0-62.0) | < 0.001 |
| Pan-immune-inflammation value | 561 (320-980) | 1399 (850-2100) | 0.005 |
| Triglyceride-glucose index | 8.8 (8.4-9.2) | 9.0 (8.6-9.4) | 0.18 |
| Atherogenic index of plasma | 0.26 (0.14-0.39) | 0.29 (0.17-0.41) | 0.31 |
| De Ritis ratio (AST/ALT) | 1.12 (0.94-1.34) | 1.18 (0.97-1.42) | 0.27 |
- Citation: Becirovic E, Becirovic M, Hodzic J, Becirovic A, Bajric M, Abdic A, Sabanovic F, Begagic E. Stress hyperglycemia and early mortality in non-ST elevation myocardial infarction. World J Cardiol 2026; 18(5): 119429
- URL: https://www.wjgnet.com/1949-8462/full/v18/i5/119429.htm
- DOI: https://dx.doi.org/10.4330/wjc.v18.i5.119429